Global Breast Cancer Drug Trials Surged Fivefold While Reporting Gaps Persisted
A systematic review of 8,224 interventional breast cancer drug trials registered between 2000 and 2025 revealed that annual study initiations ...
A systematic review of 8,224 interventional breast cancer drug trials registered between 2000 and 2025 revealed that annual study initiations ...
A systematic review of twenty clinical trials reveals that adenovirus-based cancer vaccines reliably activate cellular immune responses with low severe ...
Researchers at Memorial Sloan Kettering Cancer Center developed an information-theoretic computational model showing that flexible T cells with loosely linked ...
A comprehensive review outlines how immune checkpoints govern cancer, autoimmunity, sepsis, viral infections, and organ transplantation through context-dependent signaling networks.
A comprehensive review analyzes how synthetic mRNA, oligonucleotides, and aptamers are advancing clinical oncology treatments beyond conventional immune therapies.
Personalized neoantigen cancer vaccines induce mutation-specific T-cell responses and show potential to improve progression-free survival in gastrointestinal cancer clinical trials.
A narrative review in Frontiers in Cell and Developmental Biology identifies SSR4 as a context-dependent component of ER protein biogenesis, ...
A new study in Frontiers in Oncology reveals that PD-L1 deletion or blockade in macrophages consistently reduces surface levels of ...
A narrative review argues that safety data from six phase 3 immunotherapy trials in resectable lung cancer may not transfer ...
A new review maps how circulating tumor cells survive immune attack in the bloodstream and outlines what evidence is still ...
A new review maps how engineered DNA and RNA aptamers could enable targeted delivery and tumor microenvironment remodeling in precision ...
Long-term results from the phase 2 NICHE-2 trial show that none of 111 patients with dMMR colon cancer treated with ...
An international research team reports that the sphingosine-1-phosphate signaling long thought to operate inside colorectal cancer cells instead builds an ...
New research in Nature Aging shows that accelerated loss of naive CD8+ T cells in middle-aged male mice shrinks lymph ...
A phase II pilot trial found that a single fecal microbiota transplantation combined with atezolizumab and bevacizumab was safe and ...
Single-cell analysis of 56 glioblastoma tumors reveals that T-cell-rich cases harbor clonally expanded, LAG3-high CD8 T cells that may be ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.